Search

everythinglearnresearchcommunity

for

Search:↓

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Araliadiol may promote hair growth like minoxidil without being toxic.

UK dermatologists commonly use corticosteroids and minoxidil to treat hair loss conditions.

New small molecule drugs could help treat hair loss.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

New treatments for hair loss are emerging, and doctors need to learn how to use them effectively.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

miR-199a-3p controls hair growth and is linked to alopecia areata.

JAK inhibitors show promise for treating various skin diseases.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.